Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development.

Berthon A, Sahut-Barnola I, Lambert-Langlais S, de Joussineau C, Damon-Soubeyrand C, Louiset E, Taketo MM, Tissier F, Bertherat J, Lefrançois-Martinez AM, Martinez A, Val P.

Hum Mol Genet. 2010 Apr 15;19(8):1561-76. doi: 10.1093/hmg/ddq029. Epub 2010 Jan 27.

2.

Analysis of the role of Igf2 in adrenal tumour development in transgenic mouse models.

Drelon C, Berthon A, Ragazzon B, Tissier F, Bandiera R, Sahut-Barnola I, de Joussineau C, Batisse-Lignier M, Lefrançois-Martinez AM, Bertherat J, Martinez A, Val P.

PLoS One. 2012;7(8):e44171. doi: 10.1371/journal.pone.0044171. Epub 2012 Aug 28.

3.

Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia.

Teulière J, Faraldo MM, Deugnier MA, Shtutman M, Ben-Ze'ev A, Thiery JP, Glukhova MA.

Development. 2005 Jan;132(2):267-77. Epub 2004 Dec 8.

4.

Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex.

Kim AC, Reuter AL, Zubair M, Else T, Serecky K, Bingham NC, Lavery GG, Parker KL, Hammer GD.

Development. 2008 Aug;135(15):2593-602. doi: 10.1242/dev.021493. Epub 2008 Jul 3.

6.

Conditionally immortalized adrenocortical cell lines at undifferentiated states exhibit inducible expression of glucocorticoid-synthesizing genes.

Mukai K, Nagasawa H, Agake-Suzuki R, Mitani F, Totani K, Yanai N, Obinata M, Suematsu M, Ishimura Y.

Eur J Biochem. 2002 Jan;269(1):69-81.

7.

Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.

Tissier F, Cavard C, Groussin L, Perlemoine K, Fumey G, Hagneré AM, René-Corail F, Jullian E, Gicquel C, Bertagna X, Vacher-Lavenu MC, Perret C, Bertherat J.

Cancer Res. 2005 Sep 1;65(17):7622-7.

8.

Precursor lesions of the adrenal gland.

van Nederveen FH, de Krijger RR.

Pathobiology. 2007;74(5):285-90. Review.

PMID:
17890895
9.

APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.

Janssen KP, Alberici P, Fsihi H, Gaspar C, Breukel C, Franken P, Rosty C, Abal M, El Marjou F, Smits R, Louvard D, Fodde R, Robine S.

Gastroenterology. 2006 Oct;131(4):1096-109. Epub 2006 Aug 16. Erratum in: Gastroenterology. 2006 Dec;131(6):2029.

PMID:
17030180
10.

Immunohistochemical study of cytochrome P-450 11 beta-hydroxylase in human adrenal cortex with mineralo- and glucocorticoid excess.

Sasano H, Okamoto M, Sasano N.

Virchows Arch A Pathol Anat Histopathol. 1988;413(4):313-8.

PMID:
3140475
11.

Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer.

Vignjevic D, Schoumacher M, Gavert N, Janssen KP, Jih G, Laé M, Louvard D, Ben-Ze'ev A, Robine S.

Cancer Res. 2007 Jul 15;67(14):6844-53.

12.

Precancerous lesions upon sporadic activation of beta-catenin in mice.

Coste I, Freund JN, Spaderna S, Brabletz T, Renno T.

Gastroenterology. 2007 Apr;132(4):1299-308. Epub 2007 Jan 21.

PMID:
17408631
13.

Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling.

Deng YZ, Chen PP, Wang Y, Yin D, Koeffler HP, Li B, Tong XJ, Xie D.

J Biol Chem. 2007 Dec 14;282(50):36571-81. Epub 2007 Oct 21.

14.

Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin.

Cadoret A, Ovejero C, Saadi-Kheddouci S, Souil E, Fabre M, Romagnolo B, Kahn A, Perret C.

Cancer Res. 2001 Apr 15;61(8):3245-9.

15.

Investigating the role of adrenal cortex in organization and differentiation of the adrenal medulla in mice.

Huang CC, Liu C, Yao HH.

Mol Cell Endocrinol. 2012 Sep 25;361(1-2):165-71. doi: 10.1016/j.mce.2012.04.004. Epub 2012 May 3.

16.

Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm.

Arola J, Liu J, Heikkilä P, Ilvesmäki V, Salmenkivi K, Voutilainen R, Kahri AI.

J Endocrinol. 2000 May;165(2):223-9.

17.

Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma.

Merle P, Kim M, Herrmann M, Gupte A, Lefrançois L, Califano S, Trépo C, Tanaka S, Vitvitski L, de la Monte S, Wands JR.

J Hepatol. 2005 Nov;43(5):854-62. Epub 2005 Jun 21.

PMID:
16098625
18.

Postoperative differentiation between unilateral adrenal adenoma and bilateral adrenal hyperplasia in primary aldosteronism by mRNA expression of the gene CYP11B2.

Enberg U, Volpe C, Höög A, Wedell A, Farnebo LO, Thorén M, Hamberger B.

Eur J Endocrinol. 2004 Jul;151(1):73-85.

19.
20.

Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization.

Yin YJ, Katz V, Salah Z, Maoz M, Cohen I, Uziely B, Turm H, Grisaru-Granovsky S, Suzuki H, Bar-Shavit R.

Cancer Res. 2006 May 15;66(10):5224-33.

Items per page

Supplemental Content

Write to the Help Desk